non-small cell lung cancer
- Health
Data from Merck’s Oncology Portfolio Highlight Significant Advances in Cancer Care at ASCO21
Darmstadt, Germany: New analyses from pivotal BAVENCIO® study reinforce unique clinical benefits across different subgroups in the treatment of advanced…
Read More » - Business Wire
Takeda Announces U.S. FDA Grants Priority Review for New Drug Application for Mobocertinib (TAK-788) as a Treatment for EGFR Exon20 Insertion+ Metastatic Non-Small Cell Lung Cancer
− Prescription Drug User Fee Act (PDUFA) Target Action Date Set for October 26, 2021 CAMBRIDGE, Mass. & OSAKA, Japan–(BUSINESS…
Read More » - Health
Boehringer Ingelheim and MD Anderson Expand Collaboration to Accelerate Development of KRAS and TRAILR2 Compounds in Lung Cancer
Ingelheim, Germany & Houston, United States: Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center today announced the…
Read More »